attia glp 1 320 – AMA 64: New insights on GLP-1 agonists (Ozempic, Wegovy, Mounjaro) - efficacy, benefits, risks, and considerations in the rapidly evolving weight-loss drug landscape I have a question about

The fifth factor is education

Clinical trials show that patients who continue GLP-1 therapy experience stable weight maintenance, while those who discontinue often see rapid weight return

[1] Causes of increased breakdown include genetic disorders such as sickle cell anemia, infections such as malaria, and certain autoimmune diseases like autoimmune hemolytic anemia

L-Carnitine: the fat-to-fuel shuttle How it works: Ferries long-chain fatty acids into mitochondria so the myocardium never runs out of energy

In this trial, acetyl-l-carnitine demonstrated the ability to slow negative cognitive changes, and supported memory and attention